Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Accelerate Diagnosti
(NQ:
AXDX
)
1.780
+0.060 (+3.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Accelerate Diagnosti
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) Shareholder Notice: Investigation over Potential Wrongdoing
January 23, 2023
San Diego, CA -- (SBWIRE) -- 01/23/2023 -- An investigation on behalf of investors in Accelerate Diagnostics, Inc. (NASDAQ: AXDX) shares over potential wrongdoing at Accelerate Diagnostics, Inc. was...
Via
SBWire
Bragar Eagel & Squire, P.C. Is Investigating Accelerate Diagnostics, and Veru and Encourages Investors to Contact the Firm
November 16, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Establishment, Accelerate Diagnostics, Instil and Unisys and Encourages Investors to Contact the Firm
November 11, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
NASDAQ:AXDX Investor Notice: Investigation over Possible Securities Laws Violations by Accelerate Diagnostics, Inc.
November 09, 2022
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Accelerate Diagnostics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Bragar Eagel & Squire, P.C. Is Investigating Accelerate Diagnostics, and Instil and Encourages Investors to Contact the Firm
November 06, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Establishment, FIGS, and Accelerate Diagnostics and Encourages Investors to Contact the Firm
October 31, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors
October 27, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Establishment, FIGS, and Accelerate Diagnostics and Encourages Investors to Contact the Firm
October 26, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors
October 26, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors
October 26, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ACCELERATE DIAGNOSTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Accelerate Diagnostics, Inc. on Behalf of Accelerate Diagnostics Stockholders and Encourages Investors to Contact the Firm
October 25, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm
October 25, 2022
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation – AXDX
October 24, 2022
From
Rosen Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm
October 24, 2022
From
The Schall Law Firm
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.